190 related articles for article (PubMed ID: 12835533)
1. [Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
Sugiyama A
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):393-400. PubMed ID: 12835533
[TBL] [Abstract][Full Text] [Related]
2. Effects of a typical I(Kr) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes.
Sugiyama A; Hashimoto K
Jpn J Pharmacol; 2002 Apr; 88(4):414-21. PubMed ID: 12046984
[TBL] [Abstract][Full Text] [Related]
3. Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades.
Chiba K; Sugiyama A; Satoh Y; Shiina H; Hashimoto K
Toxicol Appl Pharmacol; 2000 Nov; 169(1):8-16. PubMed ID: 11076691
[TBL] [Abstract][Full Text] [Related]
4. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Shimizu-Sasamata M; Sato S; Miyata K; Hashimoto K
Eur J Pharmacol; 2003 Apr; 466(1-2):137-46. PubMed ID: 12679150
[TBL] [Abstract][Full Text] [Related]
5. Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models.
Sugiyama A; Satoh Y; Shiina H; Takeda S; Hashimoto K
J Cardiovasc Pharmacol; 2002 Aug; 40(2):235-45. PubMed ID: 12131553
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
Kimura K; Tabo M; Mizoguchi K; Kato A; Suzuki M; Itoh Z; Omura S; Takanashi H
J Toxicol Sci; 2007 Aug; 32(3):231-9. PubMed ID: 17785940
[TBL] [Abstract][Full Text] [Related]
7. Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias.
Takahara A; Sugiyama A; Ishida Y; Satoh Y; Wang K; Nakamura Y; Hashimoto K
Br J Pharmacol; 2006 Mar; 147(6):634-41. PubMed ID: 16314854
[TBL] [Abstract][Full Text] [Related]
8. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF
J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111
[TBL] [Abstract][Full Text] [Related]
9. Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
Lu HR; Hermans AN; Gallacher DJ
Br J Pharmacol; 2012 Jun; 166(4):1490-502. PubMed ID: 22300168
[TBL] [Abstract][Full Text] [Related]
10. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs.
Cubeddu LX
Am J Ther; 2003; 10(6):452-7. PubMed ID: 14624285
[TBL] [Abstract][Full Text] [Related]
11. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
12. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
[TBL] [Abstract][Full Text] [Related]
13. Torsadogenic cardiotoxicity of antipsychotic drugs: a structural feature, potentially involved in the interaction with cardiac HERG potassium channels.
Testai L; Bianucci AM; Massarelli I; Breschi MC; Martinotti E; Calderone V
Curr Med Chem; 2004 Oct; 11(20):2691-706. PubMed ID: 15544470
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs.
Singh BN; Wadhani N
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S85-97. PubMed ID: 15378133
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog.
Webster R; Allan G; Anto-Awuakye K; Harrison A; Kidd T; Leishman D; Phipps J; Walker D
Xenobiotica; 2001; 31(8-9):633-50. PubMed ID: 11569530
[TBL] [Abstract][Full Text] [Related]
16. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
[TBL] [Abstract][Full Text] [Related]
17. Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
van Opstal JM; Schoenmakers M; Verduyn SC; de Groot SH; Leunissen JD; van Der Hulst FF; Molenschot MM; Wellens HJ; Vos MA
Circulation; 2001 Nov; 104(22):2722-7. PubMed ID: 11723026
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
Milberg P; Ramtin S; Mönnig G; Osada N; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Pharmacol; 2004 Sep; 44(3):278-86. PubMed ID: 15475823
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
[TBL] [Abstract][Full Text] [Related]
20. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
Witchel HJ; Hancox JC
Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
